DK3475417T3 - Sammensætninger og fremgangsmåder til fremstilling af benzylisoquinolin-alkaloider, morphinan-alkaloider, thebain og derivater deraf - Google Patents

Sammensætninger og fremgangsmåder til fremstilling af benzylisoquinolin-alkaloider, morphinan-alkaloider, thebain og derivater deraf Download PDF

Info

Publication number
DK3475417T3
DK3475417T3 DK17735761.3T DK17735761T DK3475417T3 DK 3475417 T3 DK3475417 T3 DK 3475417T3 DK 17735761 T DK17735761 T DK 17735761T DK 3475417 T3 DK3475417 T3 DK 3475417T3
Authority
DK
Denmark
Prior art keywords
alkaloids
thebaine
derivatives
compositions
processes
Prior art date
Application number
DK17735761.3T
Other languages
English (en)
Inventor
Peter James Facchini
Xue Chen
Jeffrey C Colbeck
Joseph Tucker
Original Assignee
Antheia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59285401&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3475417(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Antheia Inc filed Critical Antheia Inc
Application granted granted Critical
Publication of DK3475417T3 publication Critical patent/DK3475417T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/22Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • C12P17/12Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/16Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced pteridine as one donor, and incorporation of one atom of oxygen (1.14.16)
    • C12Y114/16002Tyrosine 3-monooxygenase (1.14.16.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y201/00Transferases transferring one-carbon groups (2.1)
    • C12Y201/01Methyltransferases (2.1.1)
    • C12Y201/01128(RS)-Norcoclaurine 6-O-methyltransferase (2.1.1.128)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK17735761.3T 2016-06-27 2017-06-27 Sammensætninger og fremgangsmåder til fremstilling af benzylisoquinolin-alkaloider, morphinan-alkaloider, thebain og derivater deraf DK3475417T3 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US201662355022P 2016-06-27 2016-06-27
US201662433431P 2016-12-13 2016-12-13
US201662438695P 2016-12-23 2016-12-23
US201662438702P 2016-12-23 2016-12-23
US201662438601P 2016-12-23 2016-12-23
US201662438588P 2016-12-23 2016-12-23
US201662438540P 2016-12-23 2016-12-23
US201762469006P 2017-03-09 2017-03-09
US201762514104P 2017-06-02 2017-06-02
PCT/US2017/039589 WO2018005553A1 (en) 2016-06-27 2017-06-27 Compositions and methods for making benzylisoquinoline alkaloids, morphinan alkaloids, thebaine, and derivatives thereof

Publications (1)

Publication Number Publication Date
DK3475417T3 true DK3475417T3 (da) 2023-07-24

Family

ID=59285401

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17735761.3T DK3475417T3 (da) 2016-06-27 2017-06-27 Sammensætninger og fremgangsmåder til fremstilling af benzylisoquinolin-alkaloider, morphinan-alkaloider, thebain og derivater deraf

Country Status (8)

Country Link
US (2) US11142780B2 (da)
EP (2) EP3475417B1 (da)
AU (2) AU2017290594B2 (da)
CA (1) CA3029263A1 (da)
DK (1) DK3475417T3 (da)
ES (1) ES2952733T3 (da)
IL (1) IL263947B2 (da)
WO (1) WO2018005553A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2527254B (en) 2013-03-15 2020-07-15 Univ Leland Stanford Junior Benzylisoquinoline alkaloids (BIA) Producing microbes, and methods of making and using the same
EP3066207A1 (en) 2013-11-04 2016-09-14 The Board Of Trustees Of The University Of the Leland Stanford Junior University Benzylisoquinoline alkaloid (bia) precursor producing microbes, and methods of making and using the same
CN107614688B (zh) 2015-05-04 2023-02-28 小利兰·斯坦福大学托管委员会 产生苄基异喹啉生物碱(bia)前体的微生物及其制备和使用方法
WO2016183023A1 (en) 2015-05-08 2016-11-17 The Board Of Trustees Of The Leland Stanford Junior University Methods of producing epimerases and benzylisoquinoline alkaloids
ES2952733T3 (es) 2016-06-27 2023-11-03 Antheia Inc Composiciones y métodos para preparar alcaloides de bencilisoquinolina, alcaloides de morfinano, tebaína y derivados de los mismos
WO2018000089A1 (en) 2016-06-27 2018-01-04 Serturner Corp. Polynucleotides and polypeptides useful for making alkaloid compounds
CA3043591A1 (en) 2016-10-18 2018-04-26 Antheia, Inc. Methods of producing nor-opioid and nal-opioid benzylisoquinoline alkaloids
GB2579940B (en) 2017-08-03 2022-11-30 Antheia Inc Engineered benzylisoquinoline alkaloid epimerases and methods of producing benzylisoquinoline alkaloids
CA3078818A1 (en) * 2017-09-08 2019-03-14 Intrexon Corporation Microorganisms and methods in the fermentation of benzylisoquinoline alkaloids
AU2018379410A1 (en) 2017-12-05 2020-07-23 Willow Biosciences Inc. Neopinone isomerase and methods of using
WO2019113710A1 (en) * 2017-12-15 2019-06-20 Serturner Corp. Benzylisoquinoline uptake permeases and methods of using
BR112020016083A2 (pt) * 2018-02-08 2020-12-15 Antheia, Inc. Métodos de produção de alcaloides morfinanos e derivados
WO2019165551A1 (en) * 2018-02-28 2019-09-06 Serturner Corp. Alkaloid biosynthesis facilitating proteins and methods of use
WO2019243624A1 (en) 2018-06-22 2019-12-26 Valorbec, Limited Partnership Production of benzylisoquinoline alkaloids in recombinant hosts
EP3908654A1 (en) 2019-01-11 2021-11-17 River Stone Biotech ApS Recombinant host cells with improved production of l-dopa, dopamine, (s)-norcoclaurine or derivatives thereof
WO2024100063A1 (en) 2022-11-08 2024-05-16 River Stone Biotech Aps Genetically modified benzylisoquinoline alkaloid-producing host cells with modified efflux transporter gene expression

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268463A (en) 1986-11-11 1993-12-07 Jefferson Richard A Plant promoter α-glucuronidase gene construct
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5543508A (en) 1987-12-15 1996-08-06 Gene Shears Pty. Limited Ribozymes
US5658772A (en) 1989-12-22 1997-08-19 E. I. Du Pont De Nemours And Company Site-specific recombination of DNA in plant cells
US6067749A (en) 1996-07-11 2000-05-30 Tasmanian Alkaloids Pty. Ltd. Papaver somniferum strain with high concentration of thebaine and oripavine
AU2000280409A1 (en) * 1999-10-20 2004-02-12 Board Of Trustees Of The University Of Illinois Soybean promoter expressed preferentially in pods
AU2002211669A1 (en) 2000-10-12 2002-04-22 Robert Corcoran Purification of substance by reaction affinity chromatography
US8975063B2 (en) 2006-10-19 2015-03-10 California Institute Of Technology Compositions and methods for producing benzylisoquinoline alkaloids
US7671204B2 (en) 2007-12-17 2010-03-02 Mallinckrodt Inc. N-demethylation of N-methyl morphinans
WO2011058446A2 (en) 2009-11-12 2011-05-19 Uti Limited Partnership Thebaine 6-o-demethylase and codeine o-demethylase from papaver somniferum
RU2729065C2 (ru) 2013-12-04 2020-08-04 Эпимерон Инк. Композиции и способы получения (R)-ретикулина и его предшественников
AU2015261278C1 (en) 2014-05-16 2021-06-03 Sun Pharmaceutical Industries (Australia) Pty Limited Novel cytochrome P450 fusion protein
ES2952733T3 (es) 2016-06-27 2023-11-03 Antheia Inc Composiciones y métodos para preparar alcaloides de bencilisoquinolina, alcaloides de morfinano, tebaína y derivados de los mismos

Also Published As

Publication number Publication date
AU2022203287A1 (en) 2022-06-02
ES2952733T3 (es) 2023-11-03
IL263947B2 (en) 2023-02-01
EP3475417A1 (en) 2019-05-01
US11142780B2 (en) 2021-10-12
IL263947A (en) 2019-02-28
AU2017290594B2 (en) 2022-02-17
IL263947B (en) 2022-10-01
EP4253531A3 (en) 2023-10-25
EP4253531A2 (en) 2023-10-04
AU2017290594A1 (en) 2019-01-24
CA3029263A1 (en) 2018-01-04
US20200140906A1 (en) 2020-05-07
US20220205004A1 (en) 2022-06-30
EP3475417B1 (en) 2023-05-24
WO2018005553A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
DK3475417T3 (da) Sammensætninger og fremgangsmåder til fremstilling af benzylisoquinolin-alkaloider, morphinan-alkaloider, thebain og derivater deraf
DK3312177T3 (da) Tricyklisk derivatforbindelse, fremgangsmåde til at fremstille samme og farmaceutisk sammensætning omfattende samme
DK3433256T3 (da) 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinolinderivat, der er anvendeligt til behandling af cancer
DK3294865T3 (da) Fremgangsmåder til fremstilling af epimeraser og benzylisoquinolinalkaloider
DK3524595T3 (da) Quinolinderivat af høj renhed og fremgangsmåde til fremstilling deraf
DK3393655T3 (da) Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme
MA41898A (fr) Dérivés de quinazolinone bicyclique
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3325482T3 (da) Fremgangsmåder til fremstilling af cytotoksiske benzodiazepinderivater
DK3331879T3 (da) Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne
DK3429998T3 (da) Fremgangsmåde til fremstilling af quinolin-2-yl-phenylaminderivater og disses salte
SG11201805869XA (en) Quinolin-2-one derivatives
DK3280408T3 (da) Fremgangsmåde til fremstilling af dicycloplatin
DK3081263T3 (da) Sammensætninger og redskaber til behandling af glaukom
DK3668358T3 (da) Indretning til tilberedning af varme drikke
IL260465B (en) A process for preparing an antibody-rifamycin conjugate
DK3251523T3 (da) Fremgangsmåde til fremstilling af granuleret tilskudsfoder
IL263172A (en) The history of three-ring heterocycles, their preparation and use
DK3265443T3 (da) Pyrrolidincarboxamidderivater og fremgangsmåde til fremstilling og anvendelse af samme
DK3460102T3 (da) Fremgangsmåde til fremstilling af en elektrokatalysator
HUE049575T2 (hu) Eljárás anilin vagy egy anilin-származék elõállítására
MA41790A (fr) Dérivé de morphinane
DK3242888T3 (da) Opløselige fgfr3-atrapper til behandling af skeletvækstforstyrrelser
EP3183348A4 (en) Compositions and methods for making alkaloid morphinans
DK3397621T3 (da) Fremgangsmåde til fremstilling af 1,1,3-trioxo-1,2-benzothiazol-6-carboxamid